STAT3 and neoplasm: It also downregulates programmed death ligand-1 (PD-L1) expression and impairs the Janus kinase 1/2 (JAK1/2)-signal transduction and activator of transcription 3 (STAT3) signaling pathway, which are key factors in tumor immune evasion and metastasis79.